Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial
- PMID: 20512042
- DOI: 10.1097/YIC.0b013e32833b3242
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial
Abstract
This study was performed to investigate the anxiolytic efficacy of silexan, a new oral lavender oil capsule preparation, in comparison to placebo in primary care. In 27 general and psychiatric practices 221 adults suffering from anxiety disorder not otherwise specified (Diagnostic and Statistical Manual of Mental disorders-IV 300.00 or International Statistical Classification of Diseases and Related Health Problems, Tenth revision F41.9) were randomized to 80 mg/day of a defined, orally administered preparation from Lavandula species or placebo for 10 weeks with visits every 2 weeks. A Hamilton Anxiety Scale (HAMA) total score >or=18 and a total score >5 for the Pittsburgh Sleep Quality Index (PSQI) were required. The primary outcome measures were HAMA and PSQI total score decrease between baseline and week 10. Secondary efficacy measures included the Clinical Global Impressions scale, the Zung Self-rating Anxiety Scale, and the SF-36 Health Survey Questionnaire. Patients treated with silexan showed a total score decrease by 16.0+/-8.3 points (mean+/-SD, 59.3%) for the HAMA and by 5.5+/-4.4 points (44.7%) for the PSQI compared to 9.5+/-9.1 (35.4%) and 3.8+/-4.1 points (30.9%) in the placebo group (P<0.01 one-sided, intention to treat). Silexan was superior to placebo regarding the percentage of responders (76.9 vs. 49.1%, P<0.001) and remitters (60.6 vs. 42.6%, P=0.009). Lavandula oil preparation had a significant beneficial influence on quality and duration of sleep and improved general mental and physical health without causing any unwanted sedative or other drug specific effects. Lavandula oil preparation silexan is both efficacious and safe for the relief of anxiety disorder not otherwise specified. It has a clinically meaningful anxiolytic effect and alleviates anxiety related disturbed sleep.
Similar articles
-
Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.Eur Neuropsychopharmacol. 2015 Nov;25(11):1960-7. doi: 10.1016/j.euroneuro.2015.07.024. Epub 2015 Aug 7. Eur Neuropsychopharmacol. 2015. PMID: 26293583 Clinical Trial.
-
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.Phytomedicine. 2010 Feb;17(2):94-9. doi: 10.1016/j.phymed.2009.10.006. Epub 2009 Dec 3. Phytomedicine. 2010. PMID: 19962288 Clinical Trial.
-
An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.Int J Psychiatry Clin Pract. 2013 Nov;17 Suppl 1:15-22. doi: 10.3109/13651501.2013.813555. Epub 2013 Aug 3. Int J Psychiatry Clin Pract. 2013. PMID: 23808618 Review.
-
Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.Int J Neuropsychopharmacol. 2014 Jun;17(6):859-69. doi: 10.1017/S1461145714000017. Epub 2014 Jan 23. Int J Neuropsychopharmacol. 2014. PMID: 24456909 Clinical Trial.
-
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.Wien Med Wochenschr. 2010 Dec;160(21-22):547-56. doi: 10.1007/s10354-010-0845-7. Wien Med Wochenschr. 2010. PMID: 21170695 Review.
Cited by
-
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial.Eur Arch Psychiatry Clin Neurosci. 2024 Apr 1. doi: 10.1007/s00406-024-01783-2. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38558147
-
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials.Eur Psychiatry. 2024 Mar 1;67(1):e23. doi: 10.1192/j.eurpsy.2024.16. Eur Psychiatry. 2024. PMID: 38425206 Free PMC article. Review.
-
Current state of research on the clinical benefits of herbal medicines for non-life-threatening ailments.Front Pharmacol. 2023 Sep 28;14:1234701. doi: 10.3389/fphar.2023.1234701. eCollection 2023. Front Pharmacol. 2023. PMID: 37841934 Free PMC article.
-
Partnering essential oils with antibiotics: proven therapies against bovine Staphylococcus aureus mastitis.Front Cell Infect Microbiol. 2023 Sep 15;13:1265027. doi: 10.3389/fcimb.2023.1265027. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37790910 Free PMC article.
-
Aromatherapy for the brain: Lavender's healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer's disease: A review article.Heliyon. 2023 Jul 20;9(8):e18492. doi: 10.1016/j.heliyon.2023.e18492. eCollection 2023 Aug. Heliyon. 2023. PMID: 37554839 Free PMC article. Review.
